Zeno Di Valerio
Overview
Explore the profile of Zeno Di Valerio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
238
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Di Valerio Z, Fortuna D, Montalti M, Alberghini L, Leucci A, Saponaro A, et al.
Epidemiol Psychiatr Sci
. 2024 Nov;
33:e62.
PMID: 39508311
Background: Depressive disorders are a major public health issue in Western societies, particularly among adolescents, young adults and women. The COVID-19 pandemic has exacerbated mental health challenges, increasing depression and...
2.
Salussolia A, Capodici A, Scognamiglio F, La Fauci G, Solda G, Montalti M, et al.
BMC Infect Dis
. 2024 Apr;
24(1):438.
PMID: 38658871
Background: Herpes Zoster is an age dependent disease and as such it represents a problem in the Italian social context, where the demographic curve is characterized by an overrepresentation of...
3.
Capodici A, Salussolia A, La Fauci G, Di Valerio Z, Montalti M, Odone A, et al.
Vaccines (Basel)
. 2024 Mar;
12(3).
PMID: 38543931
Influenza is a significant public health concern, with Italy being profoundly impacted annually. Despite extensive vaccination campaigns and cooperative initiatives between the Public Health Departments of Local Healthcare Authorities and...
4.
La Fauci G, Solda G, Di Valerio Z, Salussolia A, Montalti M, Scognamiglio F, et al.
BMC Public Health
. 2024 Mar;
24(1):770.
PMID: 38475736
Introduction: The World Health Organization defines rotavirus as among the most severe causes of viral gastroenteritis affecting children under 5 year old. Italy and other European countries do not release...
5.
Di Valerio Z, La Fauci G, Scognamiglio F, Salussolia A, Montalti M, Capodici A, et al.
BMC Public Health
. 2024 Mar;
24(1):736.
PMID: 38454392
Background: Streptococcus pneumoniae infections, including Invasive Pneumococcal Diseases (IPDs), pose a substantial public health challenge, causing significant morbidity and mortality, especially among children and older adults. Vaccination campaigns have played...
6.
Montalti M, Salussolia A, Capodici A, Scognamiglio F, Di Valerio Z, La Fauci G, et al.
Vaccines (Basel)
. 2024 Feb;
12(2).
PMID: 38400170
Background: Human Papillomavirus (HPV) vaccination rates are still below the target due to vaccine refusal or delay, lack of knowledge, and logistical challenges. Understanding these barriers is crucial for developing...
7.
Capodici A, Montalti M, Solda G, Salussolia A, La Fauci G, Di Valerio Z, et al.
Hum Vaccin Immunother
. 2023 Oct;
19(2):2252250.
PMID: 37846766
Influenza annually claims an estimated 8,000 lives in Italy. Despite no-cost vaccinations for high-risk groups, hesitancy persists. This study aims to pinpoint social and behavioral vaccination determinants, forming strategies to...
8.
Montalti M, Di Valerio Z, Angelini R, Bovolenta E, Castellazzi F, Cleva M, et al.
Vaccines (Basel)
. 2023 Jul;
11(7).
PMID: 37514979
In August 2022, Italy launched a vaccination campaign to combat the spread of the monkeypox virus, which the WHO has designated as a public health emergency. Priority targets for the...
9.
Gori D, Capodici A, La Fauci G, Montalti M, Salussolia A, Solda G, et al.
Vaccines (Basel)
. 2023 Apr;
11(4).
PMID: 37112751
Background: Vaccine hesitancy was defined by the World Health Organization (WHO) in 2019 as a major threat to global health. In Italy, reluctance to receive vaccines is a widespread phenomenon...
10.
Montalti M, Guaraldi F, Di Valerio Z, Ragghianti B, Tedesco D, Mannucci E, et al.
Hum Vaccin Immunother
. 2022 Aug;
18(6):2106747.
PMID: 35944074
Pregnant and breastfeeding women (PBW) have been excluded from COVID-19 vaccine registry and the majority of post-marketing trials, despite the recognized increased risk of severe infections and complications. The lack...